ConditionsAortic AneurysmAortic DissectionBicuspid Aortic Valve (BAV)Heart FailureCardiovascular Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Michigan
About this trial
The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Any patient over the age of 18 who is able/willing to give informed consent
Patients <18 years of age with parental consent and assent (if assent is applicable for their age)
aortic pathology potentially due to a known or suspected inherited condition
Idiopathic aortic aneurysm
Disqualifiers
None
Trial population
Outpatient clinic
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
15,000 Participants
are grouped into 2 trial groupsGroup A: Aortic Disease
Group B: Controls
Trial outcomes
Primary outcomes
1
Establishing a biobank of patients with Aortic Disease
Establish a biobank of blood, serum, plasma, tissue, and clinical data of patients with any form of aortic disease
Time frame
40 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov